Tonix Pharmaceuticals
TNXP
#10306
Rank
C$66.31 M
Marketcap
C$3.41
Share price
-6.67%
Change (1 day)
-85.51%
Change (1 year)

Earnings for Tonix Pharmaceuticals (TNXP)

Earnings in 2026 (TTM): -C$0.23 Billion

According to Tonix Pharmaceuticals's latest financial reports the company's current earnings are C$29.1 Million. In 2025 the company made an earning of -C$0.18 Billion a decrease over its 2024 earnings that were of -C$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Tonix Pharmaceuticals from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.23 Billion29.99%
2025 -C$0.18 Billion61.37%
2024 -C$0.11 Billion-36.5%
2023 -C$0.17 Billion5.61%
2022 -C$0.17 Billion21.43%
2021 -C$0.14 Billion82.76%
2020 -C$72.44 Million75.22%
2019 -C$41.34 Million9.52%
2018 -C$37.75 Million23.63%
2017 -C$30.54 Million-45.36%
2016 -C$55.89 Million-19.09%
2015 -C$69.07 Million74.15%
2014 -C$39.66 Million153.99%
2013 -C$15.62 Million
2011 -C$7.54 Million29538.74%
2010 -C$0.03 Million-42.58%
2009 -C$0.05 Million46.05%
2008 -C$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Aerie Pharmaceuticals
AERI
-C$33.33 Million-85.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
C$51.13 M-121.96%๐Ÿ‡บ๐Ÿ‡ธ USA